Utah Medical Products (NASDAQ:UTMD) Stock Rating Upgraded by TheStreet

Utah Medical Products (NASDAQ:UTMD) was upgraded by research analysts at TheStreet from a “c” rating to a “b-” rating in a research report issued on Tuesday, TheStreetRatingsTable reports.

Several other equities analysts also recently issued reports on the stock. ValuEngine raised shares of Utah Medical Products from a “hold” rating to a “buy” rating in a report on Monday, October 12th. BidaskClub raised shares of Utah Medical Products from a “hold” rating to a “buy” rating in a report on Wednesday.

UTMD stock opened at $81.51 on Tuesday. The firm has a market cap of $296.94 million, a PE ratio of 24.26 and a beta of 0.35. The firm’s fifty day moving average is $81.42 and its 200 day moving average is $85.99. Utah Medical Products has a one year low of $75.33 and a one year high of $112.26.

Utah Medical Products (NASDAQ:UTMD) last released its quarterly earnings results on Tuesday, July 28th. The medical instruments supplier reported $0.36 EPS for the quarter. The company had revenue of $8.79 million for the quarter. Utah Medical Products had a net margin of 28.44% and a return on equity of 12.38%.

Several large investors have recently bought and sold shares of the company. AQR Capital Management LLC lifted its stake in shares of Utah Medical Products by 2.0% in the first quarter. AQR Capital Management LLC now owns 14,357 shares of the medical instruments supplier’s stock worth $1,350,000 after buying an additional 281 shares in the last quarter. Cardinal Capital Management lifted its stake in shares of Utah Medical Products by 3.2% in the third quarter. Cardinal Capital Management now owns 9,571 shares of the medical instruments supplier’s stock worth $764,000 after buying an additional 299 shares in the last quarter. Alliancebernstein L.P. lifted its stake in shares of Utah Medical Products by 7.1% in the first quarter. Alliancebernstein L.P. now owns 4,500 shares of the medical instruments supplier’s stock worth $423,000 after buying an additional 300 shares in the last quarter. Bessemer Group Inc. lifted its stake in shares of Utah Medical Products by 2.3% in the second quarter. Bessemer Group Inc. now owns 13,200 shares of the medical instruments supplier’s stock worth $1,170,000 after buying an additional 300 shares in the last quarter. Finally, Advisor Group Holdings Inc. purchased a new position in shares of Utah Medical Products in the first quarter worth about $33,000. 73.98% of the stock is currently owned by hedge funds and other institutional investors.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.

Featured Story: Understanding Analyst Ratings

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.